Paloma Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-43,202
Closed -$623K – 1311
2024
Q2
$623K Buy
+43,202
New +$690K 0.02% 660
2022
Q3
– Sell
-106,400
Closed -$2.09M – 1104
2022
Q2
$2.09M Buy
+106,400
New +$2.52M 0.07% 260
2022
Q1
– Sell
-130,885
Closed -$3.71M – 1891
2021
Q4
$3.71M Buy
+130,885
New +$4.07M 0.06% 281
2021
Q3
– Sell
-245,313
Closed -$8.51M – 1314
2021
Q2
$8.51M Buy
245,313
+135,818
+124% +$4.48M 0.15% 107
2021
Q1
$3.23M Buy
+109,495
New +$3.37M 0.07% 251
2020
Q3
– Sell
-40,861
Closed -$876K – 2176
2020
Q2
$876K Buy
+40,861
New +$903K 0.02% 978
2020
Q1
– Sell
-15,369
Closed -$1K – 1459
2019
Q4
$1K Sell
15,369
-99,720
-87% -$2.71M ﹤0.01% 2099
2019
Q3
$2.65M Buy
115,089
+103,389
+884% +$3.1M 0.06% 315
2019
Q2
$395K Buy
+11,700
New +$380K 0.01% 1156

Other funds holding ELAN

Paloma Partners's ELAN Position: Q3 2024 in Review

Paloma Partners sold out of Elanco Animal Health (ELAN) in Q3 2024, closing a stake of 43,202 shares — an estimated $623K sold.

Paloma Partners first reported a position in ELAN in Q2 2019 and held it in 9 quarters. The position peaked at $8.51M in Q2 2021. 388 funds tracked by Wall St. Rank hold ELAN as of Q3 2024.

  • Paloma Partners reported no remaining Elanco Animal Health position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 43,202 Elanco Animal Health shares in Q3 2024, an estimated $623K.
  • Paloma Partners first reported a position in Elanco Animal Health in Q2 2019 and held it in 9 quarters.
  • Paloma Partners's Elanco Animal Health position peaked at $8.51M in Q2 2021.
  • 388 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.